The enzymatic activity of a C-terminally truncated form of the RNA-dependent RNA polymerase, termed NS5B(Delta21), of the hepatitis C virus (strain BK) has been investigated using both homopolymeric and heteropolymeric RNA templates. Incorporation of nucleotides into a heteropolymeric RNA template as catalyzed by NS5B(Delta21) is characterized by biphasic reaction time courses. At high concentrations of nucleoside triphosphate in reactions allowing a preincubation of NS5B(Delta21) and RNA template, an initial rapid phase of the reaction is followed by a slower linear phase. The amplitude of the first phase of the reaction varies directly with the concentration of the enzyme in the reaction. It is shown here that full-length copies of the template are produced during the first phase of the reaction. Our results reveal that NS5B(Delta21) is processive but only a small fraction, less than 1%, of the purified enzyme present participates productively in the reaction. Most importantly, the turnover number for the hepatitis C NS5B(Delta21) is comparable to those observed for other polymerases such as the HIV-1 reverse transcriptase. The combined results reconcile in part the apparent discrepancy of the low, observed specific activity of the purified enzyme and the rapid generation of HCV in vivo.
Background: LpxC is a metal-dependent deacetylase essential for lipopolysaccharide biosynthesis. Results: The LpxC reaction product binds an extensive, conserved groove with the 2-amino group positioned in the active site. Conclusion: The product-bound LpxC structure reveals conserved ligand interactions and stabilization of a phosphate mimic of the oxyanion intermediate. Significance: LpxC structures are critical to elucidate the catalytic mechanism and design of novel antibiotics.
p70 ribosomal S6 kinase (p70S6K) is a downstream effector of the mTOR signaling pathway involved in cell proliferation, cell growth, cell-cycle progression, and glucose homeostasis. Multiple phosphorylation events within the catalytic, autoinhibitory, and hydrophobic motif domains contribute to the regulation of p70S6K. We report the crystal structures of the kinase domain of p70S6K1 bound to staurosporine in both the unphosphorylated state and in the 3-phosphoinositide-dependent kinase-1-phosphorylated state in which Thr-252 of the activation loop is phosphorylated. Unphosphorylated p70S6K1 exists in two crystal forms, one in which the p70S6K1 kinase domain exists as a monomer and the other as a domain-swapped dimer. The crystal structure of the partially activated kinase domain that is phosphorylated within the activation loop reveals conformational ordering of the activation loop that is consistent with a role in activation. The structures offer insights into the structural basis of the 3-phosphoinositide-dependent kinase-1-induced activation of p70S6K and provide a platform for the rational structure-guided design of specific p70S6K inhibitors.The ribosomal S6 kinase family belongs to the AGC 3 subfamily of serine-threonine protein kinases. In humans two forms of p70 ribosomal S6 kinases (S6K1 and S6K2) have been reported that are encoded by two different genes (RPS6KB1 and RPS6KB2), respectively (1, 2). RPS6KB1 encodes two isoforms that differ only at the N termini by 23 amino acid residues (2). The longer form of S6K1 contains an N-terminal nuclear localization signal, whereas the shorter isoform of S6K1 predominantly localizes in the cytosol.Several substrates of p70S6K have been identified including 40 S ribosomal protein S6, insulin substrate (IRS1), preapoptotic protein BAD, eukaryotic initiation factor (elF4B), eukaryotic elongation factor (eEF2K) and cAMP-response element modulator (CREMt) (3). The most studied substrate is the 40 S ribosomal protein S6, a major component of the machinery involved in protein synthesis in mammalian cells, suggesting that p70S6K plays a role in regulating translation.Several observations suggest a role for p70S6K in cancer (4, 5). For example, upstream regulators of p70S6K are deregulated in multiple types of cancer, and gene and protein overexpression is observed in various cancers (4, 5). In addition, p70S6K is also a downstream kinase of insulin receptor-mediated signaling and is a potential therapeutic target for the management of obesity and diabetes as shown by enhanced metabolic rate and insulin sensitivity in p70S6K knock-out mice (4, 5).The activation of p70S6K requires multiple phosphorylation events in both the kinase and autoinhibitory domains (Fig. 1). The C-terminal autoinhibitory domain, which is believed to block phosphorylation within the hydrophobic motif and the activation loop, is phosphorylated by upstream kinases such as ERK (6, 7). Other activating phosphorylation events occur at Thr-412 in the hydrophobic motif by mTOR (mammalian target of rapam...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.